Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders
Brain diseases and disorders such as Alzheimer disease, Parkinson disease, depression, schizophrenia, autism, and addiction lead to reduced quality of daily life through abnormal thoughts, perceptions, emotional states, and behavior. While the underlying mechanisms remain poorly understood, human an...
Uložené v:
| Vydané v: | International neurourology journal Ročník 20; číslo Suppl 1; s. S2 - 7 |
|---|---|
| Hlavní autori: | , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Korea (South)
Korean Continence Society
01.05.2016
대한배뇨장애요실금학회 |
| Predmet: | |
| ISSN: | 2093-6931, 2093-4777, 2093-6931 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Brain diseases and disorders such as Alzheimer disease, Parkinson disease, depression, schizophrenia, autism, and addiction lead to reduced quality of daily life through abnormal thoughts, perceptions, emotional states, and behavior. While the underlying mechanisms remain poorly understood, human and animal studies have supported a role of neuroinflammation in the etiology of these diseases. In the central nervous system, an increased inflammatory response is capable of activating microglial cells, leading to the release of pro-inflammatory cytokines including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α. In turn, the pro-inflammatory cytokines aggravate and propagate neuroinflammation, degenerating healthy neurons and impairing brain functions. Therefore, activated microglia may play a key role in neuroinflammatory processes contributing to the pathogenesis of psychiatric disorders and neurodegeneration. |
|---|---|
| AbstractList | Brain diseases and disorders such as Alzheimer disease, Parkinson disease, depression, schizophrenia, autism, and addiction lead to reduced quality of daily life through abnormal thoughts, perceptions, emotional states, and behavior. While the underlying mechanisms remain poorly understood, human and animal studies have supported a role of neuroinflammation in the etiology of these diseases. In the central nervous system, an increased inflammatory response is capable of activating microglial cells, leading to the release of pro-inflammatory cytokines including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α.
In turn, the pro-inflammatory cytokines aggravate and propagate neuroinflammation, degenerating healthy neurons and impairing brain functions. Therefore, activated microglia may play a key role in neuroinflammatory processes contributing to the pathogenesis of psychiatric disorders and neurodegeneration. KCI Citation Count: 133 Brain diseases and disorders such as Alzheimer disease, Parkinson disease, depression, schizophrenia, autism, and addiction lead to reduced quality of daily life through abnormal thoughts, perceptions, emotional states, and behavior. While the underlying mechanisms remain poorly understood, human and animal studies have supported a role of neuroinflammation in the etiology of these diseases. In the central nervous system, an increased inflammatory response is capable of activating microglial cells, leading to the release of pro-inflammatory cytokines including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α. In turn, the pro-inflammatory cytokines aggravate and propagate neuroinflammation, degenerating healthy neurons and impairing brain functions. Therefore, activated microglia may play a key role in neuroinflammatory processes contributing to the pathogenesis of psychiatric disorders and neurodegeneration.Brain diseases and disorders such as Alzheimer disease, Parkinson disease, depression, schizophrenia, autism, and addiction lead to reduced quality of daily life through abnormal thoughts, perceptions, emotional states, and behavior. While the underlying mechanisms remain poorly understood, human and animal studies have supported a role of neuroinflammation in the etiology of these diseases. In the central nervous system, an increased inflammatory response is capable of activating microglial cells, leading to the release of pro-inflammatory cytokines including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α. In turn, the pro-inflammatory cytokines aggravate and propagate neuroinflammation, degenerating healthy neurons and impairing brain functions. Therefore, activated microglia may play a key role in neuroinflammatory processes contributing to the pathogenesis of psychiatric disorders and neurodegeneration. Brain diseases and disorders such as Alzheimer disease, Parkinson disease, depression, schizophrenia, autism, and addiction lead to reduced quality of daily life through abnormal thoughts, perceptions, emotional states, and behavior. While the underlying mechanisms remain poorly understood, human and animal studies have supported a role of neuroinflammation in the etiology of these diseases. In the central nervous system, an increased inflammatory response is capable of activating microglial cells, leading to the release of pro-inflammatory cytokines including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α. In turn, the pro-inflammatory cytokines aggravate and propagate neuroinflammation, degenerating healthy neurons and impairing brain functions. Therefore, activated microglia may play a key role in neuroinflammatory processes contributing to the pathogenesis of psychiatric disorders and neurodegeneration. |
| Author | Kim, Byung Sun Im, Heh-In Hong, Heeok |
| Author_xml | – sequence: 1 givenname: Heeok surname: Hong fullname: Hong, Heeok – sequence: 2 givenname: Byung Sun surname: Kim fullname: Kim, Byung Sun – sequence: 3 givenname: Heh-In surname: Im fullname: Im, Heh-In |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27230456$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002110768$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp1UktvEzEQXqEi-qBnbmiPcEjqx9peX5CqFkqkCqqqnK1Z72zidGMHe1Mp_x4nG6oWCV_Gmvm-b56nxZEPHoviAyVTwSi_cH45pZIzSaopJ-xNccKI5hOpOT168T8uzlNakvyqShGh3hXHTDFOKiFPivYOhkVYL7bJhT7MnYW-vA89lqErf-AmBue7HlYrGFzwpfOjs8U5eozZ-YTltUsICVMJvi3v0tYuHAzR2V0gxBZjel-87aBPeH6wZ8Wvb18frr5Pbn_ezK4ubydWCD1MGoq2bhmHruoaxjtha0u1qttGAEpOa604SNEQVEqjEkR2NdOVYDWhsm6BnxWfR10fO_NonQng9nYezGM0l_cPM0MzVpI6Y2cjtg2wNOvoVhC3e8LeEeLcQByc7dHYBjTPA6YgsGJAddPQpiYtqgbBSsxaX0at9aZZYWvRDxH6V6KvI94tck1Ppqq10ERlgU8HgRh-bzANZuWSxb4Hj2GTDFWa8dy03NX98WWu5yR_V5oBFyPAxpBSxO4ZQonZ3Y3Jd2MOd2NyW5kh_mFYN-wXnot1_X95fwATpcjD |
| CitedBy_id | crossref_primary_10_1007_s10989_021_10202_2 crossref_primary_10_1186_s12974_020_01904_3 crossref_primary_10_1002_wnan_1422 crossref_primary_10_2147_JPR_S436500 crossref_primary_10_1111_bcp_14063 crossref_primary_10_1155_2018_1731289 crossref_primary_10_1186_s13041_020_00710_5 crossref_primary_10_1016_j_intimp_2023_109916 crossref_primary_10_1111_cns_12983 crossref_primary_10_1016_j_advms_2020_12_003 crossref_primary_10_1186_s12974_019_1478_4 crossref_primary_10_3389_fcell_2020_625151 crossref_primary_10_3389_fnmol_2022_947542 crossref_primary_10_3390_ijms24043798 crossref_primary_10_3390_nu11081867 crossref_primary_10_1007_s00210_024_03397_w crossref_primary_10_1097_MJT_0000000000001724 crossref_primary_10_1016_j_euroneuro_2020_03_006 crossref_primary_10_1093_ijnp_pyab083 crossref_primary_10_1016_j_dscb_2024_100128 crossref_primary_10_1038_s41598_018_24618_2 crossref_primary_10_1016_j_exger_2024_112451 crossref_primary_10_1016_j_intimp_2017_05_027 crossref_primary_10_1016_j_phanu_2020_100176 crossref_primary_10_1007_s12031_020_01678_6 crossref_primary_10_1177_0269881119845793 crossref_primary_10_1002_jnr_24184 crossref_primary_10_1111_ejn_14838 crossref_primary_10_3390_jpm11080814 crossref_primary_10_1002_tox_23451 crossref_primary_10_1159_000517798 crossref_primary_10_1016_j_bpsc_2025_05_002 crossref_primary_10_1080_87559129_2020_1762639 crossref_primary_10_1016_j_dld_2019_06_006 crossref_primary_10_3390_ijms25116215 crossref_primary_10_3390_nu15122758 crossref_primary_10_1007_s11064_024_04199_5 crossref_primary_10_3390_molecules27154961 crossref_primary_10_3390_molecules21101312 crossref_primary_10_1016_j_phrs_2021_105697 crossref_primary_10_3389_fnagi_2025_1569181 crossref_primary_10_1016_j_neubiorev_2023_105424 crossref_primary_10_3390_molecules23112850 crossref_primary_10_1007_s10522_018_9761_9 crossref_primary_10_1016_j_bbrc_2018_10_141 crossref_primary_10_1093_mutage_gez035 crossref_primary_10_1007_s11064_020_03085_0 crossref_primary_10_3892_ijmm_2016_2728 crossref_primary_10_1038_s41598_019_50228_7 crossref_primary_10_3389_fnins_2018_00628 crossref_primary_10_3390_antiox12030676 crossref_primary_10_1007_s13365_017_0597_x crossref_primary_10_1016_j_cell_2020_02_013 crossref_primary_10_1039_D4RA04761C crossref_primary_10_1016_j_lssr_2022_09_003 crossref_primary_10_1016_j_fsi_2020_06_058 crossref_primary_10_1038_s41598_025_08014_1 crossref_primary_10_1002_prca_201500076 crossref_primary_10_1016_j_intimp_2021_107431 crossref_primary_10_1016_j_numecd_2020_11_024 crossref_primary_10_1080_00207454_2023_2292951 crossref_primary_10_3390_ijms222010947 crossref_primary_10_1080_08039488_2017_1300323 crossref_primary_10_1002_cmdc_201700429 crossref_primary_10_1007_s11481_024_10101_5 crossref_primary_10_1016_j_jneuroim_2020_577232 crossref_primary_10_1016_j_pbb_2024_173788 crossref_primary_10_1159_000519552 crossref_primary_10_1016_j_jad_2019_05_009 crossref_primary_10_1016_j_coph_2018_01_010 crossref_primary_10_1016_j_cbpc_2022_109303 crossref_primary_10_1007_s11064_017_2341_6 crossref_primary_10_1016_j_mcn_2023_103855 crossref_primary_10_1039_D4RA05517A crossref_primary_10_2147_JIR_S306315 crossref_primary_10_1016_j_brainresbull_2019_02_003 crossref_primary_10_3389_fncel_2018_00307 crossref_primary_10_3389_fneur_2022_890217 crossref_primary_10_3390_ijms23158417 crossref_primary_10_1002_ardp_202400593 crossref_primary_10_1016_j_pnpbp_2024_111166 crossref_primary_10_1016_j_bbih_2019_100023 crossref_primary_10_3233_JAD_210480 crossref_primary_10_1007_s00251_017_1016_4 crossref_primary_10_1016_j_physbeh_2017_01_006 crossref_primary_10_1007_s13205_025_04455_7 crossref_primary_10_4252_wjsc_v8_i12_399 crossref_primary_10_1111_jfbc_13967 crossref_primary_10_1186_s12974_017_0865_y crossref_primary_10_31083_JIN27636 crossref_primary_10_1007_s11064_022_03650_9 crossref_primary_10_1016_j_jcyt_2022_10_014 crossref_primary_10_1016_j_cyto_2019_154879 crossref_primary_10_1016_j_heliyon_2020_e04716 crossref_primary_10_1007_s13205_025_04470_8 crossref_primary_10_1111_pcn_13078 crossref_primary_10_3390_ijms241814177 crossref_primary_10_1007_s11481_021_10033_4 crossref_primary_10_1053_j_semnuclmed_2024_01_010 crossref_primary_10_1016_j_bbalip_2019_158578 crossref_primary_10_1016_j_expneurol_2018_04_013 crossref_primary_10_3390_ijms21093219 crossref_primary_10_1016_j_neuint_2019_104499 crossref_primary_10_1055_a_1341_1907 crossref_primary_10_1371_journal_pone_0179970 crossref_primary_10_2174_0125899775298987240528050110 crossref_primary_10_1016_j_lfs_2020_117538 crossref_primary_10_1111_pde_13406 crossref_primary_10_1016_j_lfs_2018_04_057 crossref_primary_10_1017_cjn_2019_298 crossref_primary_10_3390_nu17071167 crossref_primary_10_1111_cns_13086 crossref_primary_10_1016_j_brainresbull_2020_07_016 crossref_primary_10_3389_fnbeh_2025_1622242 crossref_primary_10_3892_mmr_2025_13606 crossref_primary_10_1007_s11010_018_3401_1 crossref_primary_10_1002_hbm_23952 crossref_primary_10_1134_S0006297917030142 crossref_primary_10_1007_s00406_021_01334_z crossref_primary_10_1093_alcalc_agx043 crossref_primary_10_1016_j_jchemneu_2018_07_002 crossref_primary_10_3389_fncel_2018_00049 crossref_primary_10_1080_14728222_2023_2177532 crossref_primary_10_3389_fpsyt_2017_00024 crossref_primary_10_1016_j_jad_2017_07_008 crossref_primary_10_1007_s10735_023_10147_4 crossref_primary_10_1177_1039856217711051 crossref_primary_10_3390_brainsci10090631 crossref_primary_10_1016_j_brainres_2020_147079 crossref_primary_10_1016_j_expneurol_2020_113176 crossref_primary_10_1016_j_jff_2018_04_018 crossref_primary_10_1038_s41419_021_04404_1 crossref_primary_10_1080_15622975_2017_1349338 crossref_primary_10_1177_0269881118754680 crossref_primary_10_3390_biomedicines11061600 crossref_primary_10_1002_glia_23299 crossref_primary_10_1016_j_foodres_2020_109422 crossref_primary_10_3390_brainsci12010075 crossref_primary_10_1080_09540261_2018_1481827 crossref_primary_10_2147_IDR_S493140 crossref_primary_10_3389_fncel_2021_702685 crossref_primary_10_1002_aur_2454 crossref_primary_10_1093_qjmed_hcad095 crossref_primary_10_1007_s13596_017_0280_z crossref_primary_10_1002_cpt_557 crossref_primary_10_3389_fphar_2018_00462 crossref_primary_10_1159_000497164 crossref_primary_10_3390_ijms21103609 crossref_primary_10_1038_s41380_024_02594_6 crossref_primary_10_1007_s11011_020_00595_2 crossref_primary_10_1016_j_bbalip_2025_159663 crossref_primary_10_1038_s42003_023_04547_1 crossref_primary_10_1186_s13578_023_01000_y crossref_primary_10_3390_jcm10091809 crossref_primary_10_1007_s00406_019_01048_3 crossref_primary_10_1111_eci_12753 crossref_primary_10_1007_s11064_017_2192_1 crossref_primary_10_5498_wjp_v15_i9_108359 crossref_primary_10_3389_fnins_2017_00155 crossref_primary_10_1016_j_ijdevneu_2019_05_006 crossref_primary_10_3390_biomedicines13071731 crossref_primary_10_1016_j_pharep_2018_11_005 crossref_primary_10_1073_pnas_1811172115 crossref_primary_10_3390_ph18060867 crossref_primary_10_1002_npr2_12231 crossref_primary_10_1155_2019_3549274 crossref_primary_10_1186_s12933_021_01437_w |
| Cites_doi | 10.1016/j.pbb.2012.12.003 10.1186/1742-2094-10-46 10.1186/1742-2094-9-71 10.1017/neu.2014.24 10.1523/JNEUROSCI.4409-12.2013 10.1038/cddis.2013.59 10.1016/j.nbd.2006.06.013 10.1001/jamapsychiatry.2013.272 10.1016/j.neuroscience.2015.05.018 10.1016/j.bbi.2011.08.007 10.1186/1742-2094-10-43 10.1111/j.1600-0404.2006.00694.x 10.1016/j.bbi.2011.12.011 10.1097/PSY.0b013e3181907c1b 10.1016/j.bbi.2012.12.017 10.1016/j.neuint.2015.10.013 10.1016/j.neuropharm.2014.10.028 10.1016/j.stemcr.2014.09.004 10.1016/S1353-8020(11)70065-7 10.1126/science.278.5335.45 10.1038/npp.2009.110 10.1111/j.1440-1819.2009.01945.x 10.1007/s00401-013-1102-0 10.1016/j.pnpbp.2011.11.003 10.1523/JNEUROSCI.4847-03.2004 10.1096/fj.08-125153 10.1073/pnas.96.21.12102 10.4162/nrp.2014.8.3.267 10.1016/j.biopsych.2009.09.033 10.1186/1742-2094-8-168 10.1371/annotation/c76da2c1-ccb8-4797-94c1-359d3ceceeda 10.1155/2013/608654 10.1016/S1474-4422(09)70299-6 10.1007/s00592-012-0435-9 10.1016/j.bbadis.2010.12.017 10.1007/s10803-012-1513-0 10.7150/ijbs.4679 10.1016/j.bbr.2012.08.052 10.3389/fnins.2015.00372 10.1016/j.bbi.2006.03.005 10.1016/j.biopsych.2008.11.029 10.1016/j.nbd.2014.04.008 10.4103/2347-8659.157955 10.1038/nri3705 10.1016/j.jalz.2011.03.003 10.1097/YCO.0b013e32835aa4b4 10.1016/j.brainres.2012.03.036 10.1371/journal.pone.0088642 |
| ContentType | Journal Article |
| Copyright | Copyright © 2016 Korean Continence Society 2016 |
| Copyright_xml | – notice: Copyright © 2016 Korean Continence Society 2016 |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA ACYCR |
| DOI | 10.5213/inj.1632604.302 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals Korean Citation Index |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2093-6931 |
| EndPage | 7 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_1016608 oai_doaj_org_article_cba933021a5e42a19bb1b80de7beac6e PMC4895907 27230456 10_5213_inj_1632604_302 |
| Genre | Journal Article Review |
| GroupedDBID | --- 5-W 53G 8JR 8XY AAKDD AAYXX ABDBF ACUHS ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK E3Z EBD EF. F5P GROUPED_DOAJ HYE OK1 RPM 9ZL NPM 7X8 5PM ACYCR |
| ID | FETCH-LOGICAL-c559t-b1ec8d23af4fb23f5c8c1978db5ae6318973a65b0e779e7506f82945280168da3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 200 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000377002900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2093-6931 2093-4777 |
| IngestDate | Sun Mar 09 07:51:28 EDT 2025 Fri Oct 03 12:45:24 EDT 2025 Tue Nov 04 01:58:34 EST 2025 Sun Nov 09 10:21:34 EST 2025 Thu Jan 02 22:24:14 EST 2025 Tue Nov 18 19:56:11 EST 2025 Sat Nov 29 01:38:27 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Suppl 1 |
| Keywords | Brain Diseases Inflammation Cytokines Microglia |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c559t-b1ec8d23af4fb23f5c8c1978db5ae6318973a65b0e779e7506f82945280168da3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 G704-001728.2016.20..004 |
| ORCID | 0000-0001-6533-6064 0000-0001-9883-9063 0000-0002-4763-5009 |
| OpenAccessLink | https://doaj.org/article/cba933021a5e42a19bb1b80de7beac6e |
| PMID | 27230456 |
| PQID | 1792377968 |
| PQPubID | 23479 |
| PageCount | 6 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1016608 doaj_primary_oai_doaj_org_article_cba933021a5e42a19bb1b80de7beac6e pubmedcentral_primary_oai_pubmedcentral_nih_gov_4895907 proquest_miscellaneous_1792377968 pubmed_primary_27230456 crossref_primary_10_5213_inj_1632604_302 crossref_citationtrail_10_5213_inj_1632604_302 |
| PublicationCentury | 2000 |
| PublicationDate | 2016-05-01 |
| PublicationDateYYYYMMDD | 2016-05-01 |
| PublicationDate_xml | – month: 05 year: 2016 text: 2016-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Korea (South) |
| PublicationPlace_xml | – name: Korea (South) |
| PublicationTitle | International neurourology journal |
| PublicationTitleAlternate | Int Neurourol J |
| PublicationYear | 2016 |
| Publisher | Korean Continence Society 대한배뇨장애요실금학회 |
| Publisher_xml | – name: Korean Continence Society – name: 대한배뇨장애요실금학회 |
| References | ref13 ref12 ref15 ref14 ref53 ref52 ref11 ref10 ref17 Guadagno (ref54) 2013 Hirsch (ref20) 2012 ref51 ref50 Fahn (ref16) 2003 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 Wang (ref18) 2015 ref49 ref7 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 ref1 ref39 ref38 ref24 ref26 ref25 ref22 Wirdefeldt (ref19) 2011 ref21 ref28 ref27 ref29 (ref23) c2016 Murphy (ref9) 2010 Prince (ref8) 2015 19150053 - Biol Psychiatry. 2009 May 1;65(9):732-41 23536070 - J Neurosci. 2013 Mar 27;33(13):5553-63 22470460 - PLoS One. 2012;7(3):e33693 23404112 - JAMA Psychiatry. 2013 Jan;70(1):49-58 23196997 - Curr Opin Psychiatry. 2013 Jan;26(1):19-26 20015486 - Biol Psychiatry. 2010 Mar 1;67(5):446-57 26464797 - Transl Neurodegener. 2015 Oct 12;4:19 23570274 - J Neuroinflammation. 2013 Apr 09;10:46 16901708 - Neurobiol Dis. 2006 Oct;24(1):183-93 24533129 - PLoS One. 2014 Feb 12;9(2):e88642 26522689 - Neurochem Int. 2016 May;95:46-54 23547920 - J Neuroinflammation. 2013 Apr 01;10:43 21906670 - Brain Behav Immun. 2012 Mar;26(3):383-92 26539073 - Front Neurosci. 2015 Oct 21;9:372 19579286 - Psychiatry Clin Neurosci. 2009 Jun;63(3):257-65 23136554 - Int J Biol Sci. 2012;8(9):1254-66 22516109 - Brain Res. 2012 May 25;1456:72-81 25445485 - Neuropharmacology. 2015 Sep;96(Pt A):29-41 16647243 - Brain Behav Immun. 2007 Jan;21(1):47-59 22122877 - Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:20-34 9311924 - Science. 1997 Oct 3;278(5335):45-7 12846969 - Ann N Y Acad Sci. 2003 Jun;991:1-14 23690824 - Clin Dev Immunol. 2013;2013:608654 25981208 - Neuroscience. 2015 Aug 6;300:141-54 24962261 - Nat Rev Immunol. 2014 Jul;14 (7):463-77 14999072 - J Neurosci. 2004 Mar 3;24(9):2212-25 25418720 - Stem Cell Reports. 2014 Nov 11;3(5):725-34 22985845 - Behav Brain Res. 2013 Jan 1;236(1):270-82 22166438 - Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S210-2 21626386 - Eur J Epidemiol. 2011 Jun;26 Suppl 1:S1-58 16866919 - Acta Neurol Scand Suppl. 2006;185:107-14 20083042 - Lancet Neurol. 2010 Jan;9(1):119-28 10518583 - Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12102-7 23064949 - Acta Diabetol. 2012 Dec;49 Suppl 1:S227-34 19188531 - Psychosom Med. 2009 Feb;71(2):171-86 23305936 - Brain Behav Immun. 2013 Mar;29:136-46 24769004 - Neurobiol Dis. 2014 Aug;68:57-65 21514248 - Alzheimers Dement. 2011 May;7(3):280-92 24944770 - Nutr Res Pract. 2014 Jun;8(3):267-71 20061647 - J Alzheimers Dis. 2010;19(1):311-23 19276172 - FASEB J. 2009 Aug;23 (8):2478-89 25455257 - Acta Neuropsychiatr. 2014 Dec;26(6):334-46 23492769 - Cell Death Dis. 2013 Mar 14;4:e538 21193035 - Biochim Biophys Acta. 2012 Jan;1822(1):34-41 22251606 - Brain Behav Immun. 2012 Mar;26(3):469-79 19710631 - Neuropsychopharmacology. 2010 Jan;35(1):217-38 23262300 - Pharmacol Biochem Behav. 2013 Feb;103(4):853-9 22520439 - J Neuroinflammation. 2012 Apr 20;9:71 23512378 - Acta Neuropathol. 2013 Jul;126(1):75-91 22466688 - J Autism Dev Disord. 2012 Dec;42(12):2569-84 22129087 - J Neuroinflammation. 2011 Nov 30;8:168 |
| References_xml | – ident: ref33 doi: 10.1016/j.pbb.2012.12.003 – ident: ref2 doi: 10.1186/1742-2094-10-46 – ident: ref32 doi: 10.1186/1742-2094-9-71 – ident: ref45 doi: 10.1017/neu.2014.24 – ident: ref14 doi: 10.1523/JNEUROSCI.4409-12.2013 – volume-title: Microglia-derived TNFα induces apoptosis in neural precursor cells via transcriptional activation of the Bcl-2 family member Puma year: 2013 ident: ref54 doi: 10.1038/cddis.2013.59 – ident: ref22 doi: 10.1016/j.nbd.2006.06.013 – ident: ref39 doi: 10.1001/jamapsychiatry.2013.272 – ident: ref6 doi: 10.1016/j.neuroscience.2015.05.018 – ident: ref1 doi: 10.1016/j.bbi.2011.08.007 – volume-title: Depression. Fact Sheet No.369 2015 [Internet] year: c2016 ident: ref23 – ident: ref4 doi: 10.1186/1742-2094-10-43 – ident: ref21 doi: 10.1111/j.1600-0404.2006.00694.x – ident: ref34 doi: 10.1016/j.bbi.2011.12.011 – ident: ref25 doi: 10.1097/PSY.0b013e3181907c1b – ident: ref30 doi: 10.1016/j.bbi.2012.12.017 – ident: ref15 doi: 10.1016/j.neuint.2015.10.013 – ident: ref11 doi: 10.1016/j.neuropharm.2014.10.028 – ident: ref41 doi: 10.1016/j.stemcr.2014.09.004 – volume-title: Neuroinflammation in Parkinson’s disease year: 2012 ident: ref20 doi: 10.1016/S1353-8020(11)70065-7 – volume-title: Epidemiology and etiology of Parkinson’s disease: a review of the evidence year: 2011 ident: ref19 – ident: ref44 doi: 10.1126/science.278.5335.45 – ident: ref43 doi: 10.1038/npp.2009.110 – ident: ref51 doi: 10.1111/j.1440-1819.2009.01945.x – ident: ref29 doi: 10.1007/s00401-013-1102-0 – ident: ref50 doi: 10.1016/j.pnpbp.2011.11.003 – start-page: 1 volume-title: Description of Parkinson’s disease as a clinical syndrome year: 2003 ident: ref16 – ident: ref47 doi: 10.1523/JNEUROSCI.4847-03.2004 – ident: ref17 doi: 10.1096/fj.08-125153 – ident: ref42 doi: 10.1073/pnas.96.21.12102 – ident: ref40 doi: 10.4162/nrp.2014.8.3.267 – ident: ref26 doi: 10.1016/j.biopsych.2009.09.033 – ident: ref3 doi: 10.1186/1742-2094-8-168 – start-page: 19 volume-title: Neuroinflammation in Parkinson’s disease and its potential as therapeutic target year: 2015 ident: ref18 – ident: ref46 doi: 10.1371/annotation/c76da2c1-ccb8-4797-94c1-359d3ceceeda – ident: ref28 doi: 10.1155/2013/608654 – ident: ref12 doi: 10.1016/S1474-4422(09)70299-6 – ident: ref24 doi: 10.1007/s00592-012-0435-9 – ident: ref36 doi: 10.1016/j.bbadis.2010.12.017 – ident: ref38 doi: 10.1007/s10803-012-1513-0 – ident: ref53 doi: 10.7150/ijbs.4679 – year: 2015 ident: ref8 – ident: ref48 doi: 10.1016/j.bbr.2012.08.052 – ident: ref52 doi: 10.3389/fnins.2015.00372 – ident: ref31 doi: 10.1016/j.bbi.2006.03.005 – ident: ref27 doi: 10.1016/j.biopsych.2008.11.029 – ident: ref7 doi: 10.1016/j.nbd.2014.04.008 – ident: ref35 doi: 10.4103/2347-8659.157955 – ident: ref10 doi: 10.1038/nri3705 – start-page: 311 volume-title: Alzheimer’s disease and the β-amyloid peptide year: 2010 ident: ref9 – ident: ref13 doi: 10.1016/j.jalz.2011.03.003 – ident: ref5 doi: 10.1097/YCO.0b013e32835aa4b4 – ident: ref37 doi: 10.1016/j.brainres.2012.03.036 – ident: ref49 doi: 10.1371/journal.pone.0088642 – reference: 23305936 - Brain Behav Immun. 2013 Mar;29:136-46 – reference: 22251606 - Brain Behav Immun. 2012 Mar;26(3):469-79 – reference: 25445485 - Neuropharmacology. 2015 Sep;96(Pt A):29-41 – reference: 22129087 - J Neuroinflammation. 2011 Nov 30;8:168 – reference: 21514248 - Alzheimers Dement. 2011 May;7(3):280-92 – reference: 24533129 - PLoS One. 2014 Feb 12;9(2):e88642 – reference: 21193035 - Biochim Biophys Acta. 2012 Jan;1822(1):34-41 – reference: 26539073 - Front Neurosci. 2015 Oct 21;9:372 – reference: 20083042 - Lancet Neurol. 2010 Jan;9(1):119-28 – reference: 25981208 - Neuroscience. 2015 Aug 6;300:141-54 – reference: 23570274 - J Neuroinflammation. 2013 Apr 09;10:46 – reference: 22122877 - Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:20-34 – reference: 24769004 - Neurobiol Dis. 2014 Aug;68:57-65 – reference: 16647243 - Brain Behav Immun. 2007 Jan;21(1):47-59 – reference: 20061647 - J Alzheimers Dis. 2010;19(1):311-23 – reference: 26464797 - Transl Neurodegener. 2015 Oct 12;4:19 – reference: 21626386 - Eur J Epidemiol. 2011 Jun;26 Suppl 1:S1-58 – reference: 26522689 - Neurochem Int. 2016 May;95:46-54 – reference: 19276172 - FASEB J. 2009 Aug;23 (8):2478-89 – reference: 23262300 - Pharmacol Biochem Behav. 2013 Feb;103(4):853-9 – reference: 19150053 - Biol Psychiatry. 2009 May 1;65(9):732-41 – reference: 22466688 - J Autism Dev Disord. 2012 Dec;42(12):2569-84 – reference: 25418720 - Stem Cell Reports. 2014 Nov 11;3(5):725-34 – reference: 23547920 - J Neuroinflammation. 2013 Apr 01;10:43 – reference: 22166438 - Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S210-2 – reference: 24962261 - Nat Rev Immunol. 2014 Jul;14 (7):463-77 – reference: 16901708 - Neurobiol Dis. 2006 Oct;24(1):183-93 – reference: 25455257 - Acta Neuropsychiatr. 2014 Dec;26(6):334-46 – reference: 12846969 - Ann N Y Acad Sci. 2003 Jun;991:1-14 – reference: 23196997 - Curr Opin Psychiatry. 2013 Jan;26(1):19-26 – reference: 19710631 - Neuropsychopharmacology. 2010 Jan;35(1):217-38 – reference: 23404112 - JAMA Psychiatry. 2013 Jan;70(1):49-58 – reference: 23064949 - Acta Diabetol. 2012 Dec;49 Suppl 1:S227-34 – reference: 23512378 - Acta Neuropathol. 2013 Jul;126(1):75-91 – reference: 21906670 - Brain Behav Immun. 2012 Mar;26(3):383-92 – reference: 23492769 - Cell Death Dis. 2013 Mar 14;4:e538 – reference: 22470460 - PLoS One. 2012;7(3):e33693 – reference: 22985845 - Behav Brain Res. 2013 Jan 1;236(1):270-82 – reference: 20015486 - Biol Psychiatry. 2010 Mar 1;67(5):446-57 – reference: 23690824 - Clin Dev Immunol. 2013;2013:608654 – reference: 16866919 - Acta Neurol Scand Suppl. 2006;185:107-14 – reference: 10518583 - Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):12102-7 – reference: 19188531 - Psychosom Med. 2009 Feb;71(2):171-86 – reference: 9311924 - Science. 1997 Oct 3;278(5335):45-7 – reference: 14999072 - J Neurosci. 2004 Mar 3;24(9):2212-25 – reference: 23136554 - Int J Biol Sci. 2012;8(9):1254-66 – reference: 22520439 - J Neuroinflammation. 2012 Apr 20;9:71 – reference: 22516109 - Brain Res. 2012 May 25;1456:72-81 – reference: 23536070 - J Neurosci. 2013 Mar 27;33(13):5553-63 – reference: 24944770 - Nutr Res Pract. 2014 Jun;8(3):267-71 – reference: 19579286 - Psychiatry Clin Neurosci. 2009 Jun;63(3):257-65 |
| SSID | ssj0000447057 |
| Score | 2.4747577 |
| SecondaryResourceType | review_article |
| Snippet | Brain diseases and disorders such as Alzheimer disease, Parkinson disease, depression, schizophrenia, autism, and addiction lead to reduced quality of daily... |
| SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | S2 |
| SubjectTerms | Brain Diseases Cytokines Inflammation Microglia Review 비뇨기과학 |
| Title | Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/27230456 https://www.proquest.com/docview/1792377968 https://pubmed.ncbi.nlm.nih.gov/PMC4895907 https://doaj.org/article/cba933021a5e42a19bb1b80de7beac6e https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002110768 |
| Volume | 20 |
| WOSCitedRecordID | wos000377002900002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | International Neurourology Journal, 2016, 20(0), , pp.2-7 |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2093-6931 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000447057 issn: 2093-6931 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9QwFLagQogLYicFKoM4cEkbL_FyZKvgQDVCIM3Nsh27RK0SNDPt7-fZTkYzCMSFUyTHlhy_z2-xX76H0OvINQvCgQQcaWseiK8Vc6S2DHxvZhmNKuZiE_LsTC2XerFT6ivlhBV64LJwJ97ZFHNTYtvAqSXaOeJU0wXpQGeIkLRvI_VOMJV1MOeyyTSfFEL2mkspC68PWCt20g-gIQQ4Lg0_ZtOBymySMnM_GJphFf_kdP6eO7ljjE7vobuTF4nfltnfRzfC8ADd_jLdkz9E3QIcuzGfWszKDX8dLwMeI850HIArgEL5bRH3Q2nswnkmoU4aEH8oNzdrbIcOL-ac6N7jma9z_Qh9P_347f2neqqnUHuIGza1I8GrjjIbeXSUxdYrTyCK7Fxrg4DNrSWzonVNkFIHcCVEVFTzloIVE6qz7DE6GMYhPEXYp7p-sPkBAJH7xrtowa_x0N9S5dtYoeN5SY2fyMZTzYtLA0FHkoEBGZhJBgZkUKE32wE_C8_G37u-SzLadksE2bkBYGMm2Jh_waZCr0DC5sL3eXx6no_mYmUgjPic895Eoyr0cgaAgV2XrlLsEMartSGJdhFWSUCfJwUQ2_lQmQ7aW1EhuQeVvQnvvxn6H5nZmyvd6kYe_o8vfIbugHMnSnLmc3SwWV2FF-iWv97069URuimX6ihvml-hJBxo |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pathophysiological+Role+of+Neuroinflammation+in+Neurodegenerative+Diseases+and+Psychiatric+Disorders&rft.jtitle=International+neurourology+journal&rft.au=Hong%2C+Heeok&rft.au=Kim%2C+Byung+Sun&rft.au=Im%2C+Heh-In&rft.date=2016-05-01&rft.issn=2093-6931&rft.eissn=2093-6931&rft.volume=20&rft.issue=Suppl+1&rft.spage=S2&rft.epage=7&rft_id=info:doi/10.5213%2Finj.1632604.302&rft.externalDBID=n%2Fa&rft.externalDocID=10_5213_inj_1632604_302 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-6931&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-6931&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-6931&client=summon |